mRNA |
Epothilone B |
FIMM |
pan-cancer |
AAC |
0.28 |
0.08 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.08 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.09 |
mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
AZD6244 |
FIMM |
pan-cancer |
AAC |
-0.29 |
0.09 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.09 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.09 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.09 |
mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.1 |